PUBLICACIÓN

Sacubitril-valsartan improves anemia of cardiorenal syndrome (Crs)

ACCEDER A LA PUBLICACIÓN: Scopus Orcid

Robles N.R.; Campillejo R.D.; Valladares J.; de Vinuesa E.G.; Villa J.; Gervasini G.

2021 Cardiovascular and Hematological Agents in Medicinal Chemistry

Cardiology and Cardiovascular Medicine (Q3), Hematology (Q3), Medicine (miscellaneous) (Q3), Pharmacology (Q3)

SJR: 0.409


CITAS

5

DOI

10.2174/1871525718666200506095537

EID

2-s2.0-85102942155

ISSN

1871-5257

EISSN

1875-6182

BIBTEX

@article{Robles_2021, doi = {10.2174/1871525718666200506095537}, url = {https://doi.org/10.2174%2F1871525718666200506095537}, year = 2021, month = {may}, publisher = {Bentham Science Publishers Ltd.}, volume = {19}, number = {1}, pages = {93--97}, author = {Nicol{\'{a}}s R. Robles and Rosa D. Campillejo and Julian Valladares and Elena G. de Vinuesa and Juan Villa and Guillermo Gervasini}, title = {Sacubitril-Valsartan Improves Anemia of Cardiorenal Syndrome ({CRS})}, journal = {Cardiovascular {\&} Hematological Agents in Medicinal Chemistry} }


AUTORES DE LA UEX